A Comprehensive Review on LncRNAs / miRNAs ‐ DNMT1 Axis in Human Cancer: Mechanistic and Clinical Application
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70604 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Seyed Mohsen Aghaei-Zarch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplasms, DNA (Cytosine-5-)-Methyltransferase 1, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer constitutes a significant public health concern, and addressing the challenge of cancer holds paramount importance and requires immediate attention. Epigenetic alterations, encompassing DNA methylation, have emerged as pivotal contributors to the development of diverse cancer types. These modifications exert their influence by modulating chromatin structure, gene expression patterns and other nuclear processes, thereby influencing cancer pathogenesis. Over the last two decades, an increasing body of evidence has established the involvement of DNA methyltransferase 1 ( DNMT1 ) in various aspects of cancer development, including tumorigenesis, aggressiveness and treatment response. Furthermore, non‐coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non‐coding RNAs (lncRNAs), are increasingly recognised as significant modulators in diverse biological processes, encompassing metastasis, apoptosis, cell proliferation and differentiation. Several recent studies have elucidated the intricate relationship between epigenetic machinery, specifically DNMT1 , and the expression of ncRNAs in the context of cancer. In this review, we provide a comprehensive overview of the interaction between DNMT1 and ncRNAs in cancer pathogenesis. Furthermore, we discuss the important role of the ncRNAs‐ DNMT1 axis in cancer stem cells and cancer therapy resistance as critical issues in cancer therapy. Finally, we demonstrate that herbal medicine and synthetic RNA molecules regulate DNMT1 activity and hold great promise in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Paramedicine, Amol School of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.
- Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
ORCID-Profile: Seyed Mohsen Aghaei-Zarch
Zitieren
APA
Aghaei-Zarch, S. M., Esmaeili, A., & Bagheri-Mohammadi, S. (2025). A Comprehensive Review on LncRNAs / miRNAs ‐ DNMT1 Axis in Human Cancer: Mechanistic and Clinical Application. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70604
Vancouver
Aghaei-Zarch SM, Esmaeili A, Bagheri-Mohammadi S. A Comprehensive Review on LncRNAs / miRNAs ‐ DNMT1 Axis in Human Cancer: Mechanistic and Clinical Application. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70604
BibTeX
@article{AghaeiZarch2025,
author = {Aghaei-Zarch, Seyed Mohsen and Esmaeili, Ali and Bagheri-Mohammadi, Saeid},
title = {A Comprehensive Review on LncRNAs / miRNAs ‐ DNMT1 Axis in Human Cancer: Mechanistic and Clinical Application},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70604}
}
EUVIMED